Nir Fluman
Impact in
- Molecular Medicine top 5%
- Antibiotic Resistance in Bacteria
-
- Drug Transport and Resistance Mechanisms
Papers in
- Genetics 7
- Bacterial Genetics and Biotechnology 7
-
- DNA and Nucleic Acid Chemistry 3
- RNA and protein synthesis mechanisms 3
- Protein Structure and Dynamics 1
- Co-authors
- Eitan Bibi (7 shared papers)Julian P. Whitelegge (1 shared paper)Christopher M. Ryan (1 shared paper)Yitzhak Pilpel (1 shared paper)Gunnar von Heijne (2 shared papers)Nadejda Sigal (2 shared papers)Victor Tobiasson (1 shared paper)Julia Adler (1 shared paper)
- Journals
- Nature Communications (3 papers)Proceedings of the National Academy of Sciences (2 papers)Journal of Biological Chemistry (2 papers)Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics (1 paper)eLife (1 paper)
- Partner nations
- IsraelSwedenUnited States
In The Last Decade
Nir Fluman
10 papers receiving 426 citations
Peers
Comparison fields: 5 of 62
- Molecular Medicine 150
- Oncology 152
- Genetics 121
- Endocrinology 20
- Biochemistry 27
Countries citing papers authored by Nir Fluman
This map shows the geographic impact of Nir Fluman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nir Fluman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nir Fluman more than expected).
Fields of papers citing papers by Nir Fluman
This network shows the impact of papers produced by Nir Fluman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nir Fluman. The network helps show where Nir Fluman may publish in the future.
Co-authors
The 16 scholars most cited alongside Nir Fluman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2008 | 111 | |
| 2 | 2012 | 92 | |
| 3 | 2014 | 67 | |
| 4 | 2012 | 35 | |
| 5 | 2009 | 34 | |
| 6 | 2017 | 28 | |
| 7 | 2014 | 25 | |
| 8 | 2019 | 20 | |
| 9 | 2009 | 16 | |
| 10 | 2024 | 3 | |
| 11 | 2026 | 0 |
About Nir Fluman
Nir Fluman is a scholar working on Genetics, Molecular Biology, Oncology, Molecular Medicine and Pharmacology, having authored 11 papers that have together received 431 indexed citations. Recurring topics across this work include Bacterial Genetics and Biotechnology (7 papers), Antibiotic Resistance in Bacteria (6 papers), Drug Transport and Resistance Mechanisms (6 papers), DNA and Nucleic Acid Chemistry (3 papers), RNA and protein synthesis mechanisms (3 papers), Protein Structure and Dynamics (1 paper), Enzyme Structure and Function (1 paper) and Amino Acid Enzymes and Metabolism (1 paper). The work is most often cited by research in Molecular Medicine (150 citations), Oncology (152 citations), Genetics (121 citations), Endocrinology (20 citations) and Biochemistry (27 citations). Nir Fluman has collaborated with scholars based in Israel, Sweden and United States. Frequent co-authors include Eitan Bibi, Julian P. Whitelegge, Christopher M. Ryan, Yitzhak Pilpel, Gunnar von Heijne, Nadejda Sigal, Victor Tobiasson, Julia Adler, Nadav Sahar and Melissa H. Brown. Their work appears in journals such as Nature Communications, Proceedings of the National Academy of Sciences, Journal of Biological Chemistry, Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics and eLife.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.